Dean Investment Associates’s Meridian Bioscience Inc VIVO Stock Holding History

Dean Investment Associates’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-413,745	Closed	-$5.71M	–	223
2017 Q1	$5.71M	Buy	413,745 +156,625	+61%	+$2.19M	0.95%	29
2016 Q4	$4.55M	Buy	+257,120	New	+$4.52M	0.78%	60
2016 Q2	–	Sell	-47,775	Closed	-$985K	–	227
2016 Q1	$985K	Buy	47,775 +1,848	+4%	+$36.4K	0.2%	120
2015 Q4	$942K	Buy	45,927 +122	+0.3%	+$2.34K	0.21%	119
2015 Q3	$783K	Buy	45,805 +2,718	+6%	+$49.7K	0.18%	127
2015 Q2	$803K	Buy	43,087 +1,510	+4%	+$28K	0.18%	140
2015 Q1	$793K	Buy	41,577 +15,694	+61%	+$290K	0.18%	136
2014 Q4	$426K	Buy	25,883 +1,308	+5%	+$22.4K	0.1%	204
2014 Q3	$435K	Buy	24,575 +970	+4%	+$19.1K	0.11%	202
2014 Q2	$487K	Buy	23,605 +696	+3%	+$14.3K	0.11%	181
2014 Q1	$499K	Buy	22,909 +7,976	+53%	+$183K	0.12%	164
2013 Q4	$396K	Buy	14,933 +1,021	+7%	+$25.1K	0.09%	206
2013 Q3	$329K	Buy	13,912 +1,553	+13%	+$36.3K	0.09%	216
2013 Q2	$266K	Buy	+12,359	New	+$267K	0.08%	215

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dean Investment Associates's VIVO Position: Q2 2017 in Review

Dean Investment Associates sold out of Meridian Bioscience Inc (VIVO) in Q2 2017, closing a stake of 413,745 shares — an estimated $5.71M sold.

Dean Investment Associates first reported a position in VIVO in Q2 2013 and held it in 14 quarters. The position peaked at $5.71M in Q1 2017. 170 funds tracked by Wall St. Rank hold VIVO as of Q2 2017.

Dean Investment Associates reported no remaining Meridian Bioscience Inc position as of Q2 2017 after selling out during the quarter.
Dean Investment Associates sold 413,745 Meridian Bioscience Inc shares in Q2 2017, an estimated $5.71M.
Dean Investment Associates first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 14 quarters.
Dean Investment Associates's Meridian Bioscience Inc position peaked at $5.71M in Q1 2017.
170 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2017.

Based on Dean Investment Associates's 13F filing for Q2 2017, filed 10 Aug 2017.